These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

957 related items for PubMed ID: 23970571

  • 1. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.
    Tun W, Vu L, Adebajo SB, Abiodun L, Sheehy M, Karlyn A, Njab J, Ahonsi B, Issa BK, Idogho O.
    Int J STD AIDS; 2013 Aug; 24(8):619-25. PubMed ID: 23970571
    [Abstract] [Full Text] [Related]

  • 2. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
    Johnston L, Saumtally A, Corceal S, Mahadoo I, Oodally F.
    Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A, Razaghi EM, Sahimi-Izadian E, Amin-Esmaeili M.
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study.
    Rhodes T, Platt L, Maximova S, Koshkina E, Latishevskaya N, Hickman M, Renton A, Bobrova N, McDonald T, Parry JV.
    Addiction; 2006 Feb; 101(2):252-66. PubMed ID: 16445554
    [Abstract] [Full Text] [Related]

  • 6. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
    Shirin T, Ahmed T, Iqbal A, Islam M, Islam MN.
    J Health Popul Nutr; 2000 Dec; 18(3):145-50. PubMed ID: 11262767
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prevalence of HIV, HCV and sexually transmitted infections among injecting drug users in Rawalpindi and Abbottabad, Pakistan: evidence for an emerging injection-related HIV epidemic.
    Platt L, Vickerman P, Collumbien M, Hasan S, Lalji N, Mayhew S, Muzaffar R, Andreasen A, Hawkes S.
    Sex Transm Infect; 2009 Apr; 85 Suppl 2():ii17-22. PubMed ID: 19307346
    [Abstract] [Full Text] [Related]

  • 10. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
    Devi KhS, Singh NB, Singh HL, Singh YM.
    J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of HIV/STIs and associated factors among men who have sex with men in An Giang, Vietnam.
    Pham QD, Nguyen TV, Hoang CQ, Cao V, Khuu NV, Phan HT, Mai AH, Tran HN, Wilson DP, Zhang L.
    Sex Transm Dis; 2012 Oct; 39(10):799-806. PubMed ID: 23001268
    [Abstract] [Full Text] [Related]

  • 12. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S, Chatterjee A, Bhattacharjee S, Ray B, Saha MK, Bhattacharya SK.
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [Abstract] [Full Text] [Related]

  • 13. Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users.
    Vassilev ZP, Hagan H, Lyubenova A, Tomov N, Vasilev G, Krasteva D, Des Jarlais DC.
    Int J STD AIDS; 2006 Sep; 17(9):621-6. PubMed ID: 16942654
    [Abstract] [Full Text] [Related]

  • 14. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
    Miller ER, Hellard ME, Bowden S, Bharadwaj M, Aitken CK.
    J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. High prevalence of HIV, chlamydia and gonorrhoea among men who have sex with men and transgender women attending trusted community centres in Abuja and Lagos, Nigeria.
    Keshinro B, Crowell TA, Nowak RG, Adebajo S, Peel S, Gaydos CA, Rodriguez-Hart C, Baral SD, Walsh MJ, Njoku OS, Odeyemi S, Ngo-Ndomb T, Blattner WA, Robb ML, Charurat ME, Ake J, TRUST/RV368 Study Group.
    J Int AIDS Soc; 2016 May; 19(1):21270. PubMed ID: 27931519
    [Abstract] [Full Text] [Related]

  • 20. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
    Semá Baltazar C, Horth R, Boothe M, Sathane I, Young P, Chitsondzo Langa D, Condula M, Ricardo H, Dengo Baloi L, Cummings B, Schaad N, Gouveia L, Teodoro E, Raymond HF.
    BMC Infect Dis; 2019 Dec 02; 19(1):1022. PubMed ID: 31791273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.